Bile Duct DiseasesERVPPNCT06010576
Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy
A study testing EUS-guided rendezvous and Early precut papillotomy group in people with Bile Duct Diseases, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Selective bile duct cannulation is the most important step in endoscopic retrograde cholangiopancreatography (ERCP) for treatment of benign and malignant pancreatobiliary diseases, but it may fail in up to 15% of cases. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Bile Duct Diseases
- What is being tested?
- EUS-guided rendezvous and Early precut papillotomy group
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 188 participants
- Where
- 1 siteHong Kong
- Study dates
- 5 Sep 2023to 30 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients age 18 years or older undergoing ERCP with indication for bile duct cannulation
- Native major papilla
- Difficult bile duct cannulation, defined by the presence of 1 of the following: 1) unsuccessful bile duct cannulation within 10 cannulation attempts, 2) unsuccessful bile duct cannulation within 10 minutes spent in cannulation, or 3) 2 unintended pancreatic duct cannulation or opacification with contrast
- Written informed consent available
Who cannot join
- Unable to provide written informed consent
- Contraindications for endoscopy due to comorbidities
- Prior biliary sphincterotomy
- Surgically altered upper gastrointestinal anatomy or duodenal obstruction precluding a standard ERCP
- Uncorrectable coagulopathy (INR > 1.5) and thrombocytopenia (platelet < 50,000) by blood product transfusion
- Pregnant patients
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
Prince of Wales Hospital, The Chinese University of Hong Kong
Shatin, New Territories
Felix Sia, BS, (852) 26370428, felixsia@cuhk.edu.hk
Raymond S Tang, MD
About this study
Official title: Endoscopic Ultrasound-guided Rendezvous Technique Versus Early Precut Papillotomy for Difficult Bile Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Multicenter Randomized Controlled Trial
Selective bile duct cannulation is the most important step in endoscopic retrograde cholangiopancreatography (ERCP) for treatment of benign and malignant pancreatobiliary diseases, but it may fail in up to 15% of cases. Precut papillotomy is an advanced ERCP cannulation technique recommended by guidelines for rescue of difficult biliary access, but it is not without limitations. Endoscopic ultrasound (EUS)-guided biliary drainage is a novel interventional EUS technique that has been increasingly performed after failed biliary access by advanced ERCP cannulation techniques.
Read the detailed description
Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred therapeutic modality over surgery or interventional radiology procedures in many common benign or malignant pancreatobiliary diseases in modern clinical practice, but selective bile duct cannulation may fail in up to 15% of cases.
The implication of failed endoscopic biliary access can be substantial for the following reasons: higher risk of post-ERCP pancreatitis (PEP), need for rescue procedures such as external biliary drainage by interventional radiology, risks of external biliary drainage catheter-related complications including catheter blockage.
Advanced ERCP cannulation techniques such as pancreatic guidewire-assisted biliary cannulation with or without pancreatic stenting, and precut papillotomy are recommended by guidelines in patients with difficult bile duct cannulation, but they are not without limitations. If pancreatic duct cannulation is not feasible or pancreatic guidewire-assisted biliary cannulation fails, precut papillotomy using 1 of the 3 accepted precut techniques: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome, can be performed depending on institutional expertise. Despite a higher biliary cannulation success by precut papillotomy when compared to pancreatic guidewire-assisted biliary cannulation, a higher risk of PEP has also been traditionally associated with precut papillotomy when it is performed after prolonged cannulation attempts. On the other hand, there has been growing evidence to suggest the increased risk of PEP may be related to the persistent cannulation attempts before precut rather than the precut papillotomy itself. In a recent meta-analysis of 5 randomized controlled trials comparing "early precut papillotomy" to persistent standard cannulation techniques in ERCP by attending endoscopists and advanced endoscopy trainees, the incidence of PEP was not significantly different between the "early precut papillotomy" and the persistent standard cannulation groups.
EUS-guided rendezvous technique (EUS RV) is a novel advanced interventional EUS technique that has been increasingly performed in tertiary centers for patients with failed biliary access by advanced ERCP cannulation techniques. Several variations of EUS-guided biliary drainage procedures have been described including transpapillary drainage procedures (EUS RV for biliary access, EUS-guided antegrade stenting) and transmural drainage procedures (EUS-guided choledochoduodenostomy, EUS-guided hepaticogastrostomy). EUS RV can be applied in both benign and malignant biliary conditions as a salvage technique for difficult biliary access when the major papilla is accessible. EUS RV involves the following key steps: access of the dilated bile duct by a EUS needle under EUS guidance, performance of cholangiogram, advancement of the rendezvous guidewire into the bile duct and out of the major papilla into duodenum, and exchange of echoendoscope back to a duodenoscope to complete the procedure by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire. Because EUS RV achieves biliary access by targeting the dilated bile duct with antegrade passage of guidewire from bile duct through the papillary orifice, theoretically this would carry a lower risk of procedure-related PEP when compared to early precut papillotomy.
In a recently published consensus guidelines on the optimal management in interventional EUS procedures proposed by experts from our endoscopy research group and other member institutions of the Asian EUS Group, EUS-guided biliary drainage is recommended as the procedure of choice for biliary drainage in patients with failed ERCP when expertise is available based on high level evidence. The technical success of EUS RV has increased over time to 73% to 100% in studies published after 2012.
Studies directly comparing EUS RV and precut papillotomy in patients with difficult biliary access remain scarce. In a single center retrospective study published in 2012 comparing the clinical outcomes of 58 EUS RV procedures and 144 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, Dhir V et al reported a significantly higher first session technical success of biliary access (98% vs 90%, p = 0.038) and a lower adverse event rate (3.4% vs 6.9%, p = 0.27) in the EUS RV group. In a multicenter retrospective study published in 2017 by Lee A et al comparing the clinical outcomes of 50 EUS RV + 11 EUS-guided transmural drainage procedures and 142 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, a higher technical success of biliary access (94% vs 75%) was also demonstrated in the EUS RV group.
Despite the promising results of EUS RV in patients with failed biliary cannulation by advanced ERCP techniques, there has been no dedicated randomized controlled trial directly comparing EUS RV and early precut papillotomy in patients with difficult bile duct cannulation. We aim to conduct a multicenter randomized controlled trial comparing the clinical efficacy of these 2 advanced endoscopic biliary access techniques in patients with difficult bile duct cannulation in ERCP.
- Conditions
- Bile Duct Diseases
- Being tested
- EUS-guided rendezvous, Early precut papillotomy group
- Keywords
- ERCP, EUS
- Medical subject headings
- Bile Duct Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EUS-guided rendezvousProcedure or surgery
A linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle. Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance. The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator. Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice. The echoendoscope would then be exchanged to a duodenoscope for ERCP. The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access.
Early precut papillotomy groupProcedure or surgery
The precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome
| Study group | Role | What they receive |
|---|---|---|
| EUS-guided rendezvous group (EUS RV group) | Active comparator | In the EUS RV group, a linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle. Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance. The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator. Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice. The echoendoscope would then be exchanged to a duodenoscope for ERCP. The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access. Receives: Procedure: EUS-guided rendezvous |
| Early precut papillotomy group (EPP group) | Active comparator | In the EPP group, the precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome Receives: Procedure: Early precut papillotomy group |
What is being measured
The primary outcome is the main question the study is designed to answer.
The first session technical success for biliary access by EUS-guided rendezvous technique and early precut papillotomy in patients with difficult biliary access during ERCP
Technical success by EUS RV is defined as successful EUS-guided needle access of bile duct confirmed by bile aspiration and cholangiogram, advancement of guidewire into bile duct and out of papilla, and obtaining deep biliary cannulation by retrieving the rendezvous guidewire into duodenoscope or by cannulation alongside the rendezvous guidewire. Technical success by Early Precut Papillotomy is defined as successful bile duct access by 1 of the 3 acceptable precut techniques in achieving deep biliary cannulation, confirmed by bile aspiration and cholangiogram.
Measured: Intra-procedure, during ERCP
Secondary outcomes (3)
Procedure-related serious adverse events in the EUS-guided rendezvous group and the early precut papillotomy group within 30 days of ERCP
Procedure-related serious adverse events include perforation, bleeding, biliary sepsis, pancreatitis, bile leak, or procedure-related mortality
Measured: From day of procedure to Day 30 after procedure
Procedure time to achieve biliary access by the assigned study biliary access technique
EUS RV group: time from EUS-guided needle access of bile duct to successful biliary cannulation by ERCP. Early Precut Papillotomy group: time from precut initiation to successful biliary cannulation.
Measured: Intra-procedure, during ERCP
Need for rescue biliary drainage procedures in patients with failed biliary access by the assigned study technique, including crossover to the other study biliary access technique, need for PTBD by interventional radiology
Intra-procedure: crossover to the other study biliary access technique. Within 3 days of procedure: need for percutaneous transhepatic biliary drainage by interventional radiology
Measured: Intra-procedure (during ERCP) and 3 days post procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2023
- Study start5 Sep 2023
- Primary completion31 Dec 2026 (estimated)
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bile Duct DiseasesStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 188 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Collaborators
- Tokyo University, University of Toyama, Shizuoka Cancer Center, Tokyo Women's Medical University, Shiga University of Medical Science, Japan, Asian Institute of Gastroenterology, India, National Taiwan University Hospital
- Responsible party
- Principal investigator, Raymond Shing Yan Tang, Chinese University of Hong Kong
- Investigators
- Raymond Tang, MD, Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06010576
- Sponsor's protocol ID
- 2021.720-T
- Acronym
- ERVPP
- Status last verified
- Jul 2026
- First submitted
- 20 Aug 2023
- Last updated
- 16 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Endoscopic Ultrasound-guided Rendezvous Technique Versus Early Precut Papillotomy for Difficult Bile Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Multicenter Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06010576
- Acronym / sponsor ID
- ERVPP / 2021.720-T
- Conditions
- Bile Duct Diseases
- Keywords
- ERCP, EUS
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 188 participants (estimated)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Collaborators
- Tokyo University, University of Toyama, Shizuoka Cancer Center, Tokyo Women's Medical University, Shiga University of Medical Science, Japan, Asian Institute of Gastroenterology, India, National Taiwan University Hospital
- Study start
- 5 Sep 2023 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 30 Jun 2027 (estimated)
- First posted
- 24 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Selective bile duct cannulation is the most important step in endoscopic retrograde cholangiopancreatography (ERCP) for treatment of benign and malignant pancreatobiliary diseases, but it may fail in up to 15% of cases. Precut papillotomy is an advanced ERCP cannulation technique recommended by guidelines for rescue of difficult biliary access, but it is not without limitations. Endoscopic ultrasound (EUS)-guided biliary drainage is a novel interventional EUS technique that has been increasingly performed after failed biliary access by advanced ERCP cannulation techniques.
Detailed description
Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred therapeutic modality over surgery or interventional radiology procedures in many common benign or malignant pancreatobiliary diseases in modern clinical practice, but selective bile duct cannulation may fail in up to 15% of cases.
The implication of failed endoscopic biliary access can be substantial for the following reasons: higher risk of post-ERCP pancreatitis (PEP), need for rescue procedures such as external biliary drainage by interventional radiology, risks of external biliary drainage catheter-related complications including catheter blockage.
Advanced ERCP cannulation techniques such as pancreatic guidewire-assisted biliary cannulation with or without pancreatic stenting, and precut papillotomy are recommended by guidelines in patients with difficult bile duct cannulation, but they are not without limitations. If pancreatic duct cannulation is not feasible or pancreatic guidewire-assisted biliary cannulation fails, precut papillotomy using 1 of the 3 accepted precut techniques: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome, can be performed depending on institutional expertise. Despite a higher biliary cannulation success by precut papillotomy when compared to pancreatic guidewire-assisted biliary cannulation, a higher risk of PEP has also been traditionally associated with precut papillotomy when it is performed after prolonged cannulation attempts. On the other hand, there has been growing evidence to suggest the increased risk of PEP may be related to the persistent cannulation attempts before precut rather than the precut papillotomy itself. In a recent meta-analysis of 5 randomized controlled trials comparing "early precut papillotomy" to persistent standard cannulation techniques in ERCP by attending endoscopists and advanced endoscopy trainees, the incidence of PEP was not significantly different between the "early precut papillotomy" and the persistent standard cannulation groups.
EUS-guided rendezvous technique (EUS RV) is a novel advanced interventional EUS technique that has been increasingly performed in tertiary centers for patients with failed biliary access by advanced ERCP cannulation techniques. Several variations of EUS-guided biliary drainage procedures have been described including transpapillary drainage procedures (EUS RV for biliary access, EUS-guided antegrade stenting) and transmural drainage procedures (EUS-guided choledochoduodenostomy, EUS-guided hepaticogastrostomy). EUS RV can be applied in both benign and malignant biliary conditions as a salvage technique for difficult biliary access when the major papilla is accessible. EUS RV involves the following key steps: access of the dilated bile duct by a EUS needle under EUS guidance, performance of cholangiogram, advancement of the rendezvous guidewire into the bile duct and out of the major papilla into duodenum, and exchange of echoendoscope back to a duodenoscope to complete the procedure by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire. Because EUS RV achieves biliary access by targeting the dilated bile duct with antegrade passage of guidewire from bile duct through the papillary orifice, theoretically this would carry a lower risk of procedure-related PEP when compared to early precut papillotomy.
In a recently published consensus guidelines on the optimal management in interventional EUS procedures proposed by experts from our endoscopy research group and other member institutions of the Asian EUS Group, EUS-guided biliary drainage is recommended as the procedure of choice for biliary drainage in patients with failed ERCP when expertise is available based on high level evidence. The technical success of EUS RV has increased over time to 73% to 100% in studies published after 2012.
Studies directly comparing EUS RV and precut papillotomy in patients with difficult biliary access remain scarce. In a single center retrospective study published in 2012 comparing the clinical outcomes of 58 EUS RV procedures and 144 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, Dhir V et al reported a significantly higher first session technical success of biliary access (98% vs 90%, p = 0.038) and a lower adverse event rate (3.4% vs 6.9%, p = 0.27) in the EUS RV group. In a multicenter retrospective study published in 2017 by Lee A et al comparing the clinical outcomes of 50 EUS RV + 11 EUS-guided transmural drainage procedures and 142 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, a higher technical success of biliary access (94% vs 75%) was also demonstrated in the EUS RV group.
Despite the promising results of EUS RV in patients with failed biliary cannulation by advanced ERCP techniques, there has been no dedicated randomized controlled trial directly comparing EUS RV and early precut papillotomy in patients with difficult bile duct cannulation. We aim to conduct a multicenter randomized controlled trial comparing the clinical efficacy of these 2 advanced endoscopic biliary access techniques in patients with difficult bile duct cannulation in ERCP.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| EUS-guided rendezvous group (EUS RV group) | Active comparator | Procedure: EUS-guided rendezvousIn the EUS RV group, a linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle. Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance. The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator. Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice. The echoendoscope would then be exchanged to a duodenoscope for ERCP. The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access. |
| Early precut papillotomy group (EPP group) | Active comparator | Procedure: Early precut papillotomy groupIn the EPP group, the precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients age 18 years or older undergoing ERCP with indication for bile duct cannulation
- Native major papilla
- Difficult bile duct cannulation, defined by the presence of 1 of the following: 1) unsuccessful bile duct cannulation within 10 cannulation attempts, 2) unsuccessful bile duct cannulation within 10 minutes spent in cannulation, or 3) 2 unintended pancreatic duct cannulation or opacification with contrast
- Written informed consent available
Key exclusion criteria (6 listed)
- Unable to provide written informed consent
- Contraindications for endoscopy due to comorbidities
- Prior biliary sphincterotomy
- Surgically altered upper gastrointestinal anatomy or duodenal obstruction precluding a standard ERCP
- Uncorrectable coagulopathy (INR > 1.5) and thrombocytopenia (platelet < 50,000) by blood product transfusion
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EUS-guided rendezvousA linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle. Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance. The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator. Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice. The echoendoscope would then be exchanged to a duodenoscope for ERCP. The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access. | Procedure or surgery | EUS-guided rendezvous group (EUS RV group) |
| Early precut papillotomy groupThe precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome | Procedure or surgery | Early precut papillotomy group (EPP group) |
Primary outcome
The first session technical success for biliary access by EUS-guided rendezvous technique and early precut papillotomy in patients with difficult biliary access during ERCP
Time frame: Intra-procedure, during ERCP
Technical success by EUS RV is defined as successful EUS-guided needle access of bile duct confirmed by bile aspiration and cholangiogram, advancement of guidewire into bile duct and out of papilla, and obtaining deep biliary cannulation by retrieving the rendezvous guidewire into duodenoscope or by cannulation alongside the rendezvous guidewire. Technical success by Early Precut Papillotomy is defined as successful bile duct access by 1 of the 3 acceptable precut techniques in achieving deep biliary cannulation, confirmed by bile aspiration and cholangiogram.
3 secondary outcomes
Procedure-related serious adverse events in the EUS-guided rendezvous group and the early precut papillotomy group within 30 days of ERCP
Time frame: From day of procedure to Day 30 after procedure
Procedure time to achieve biliary access by the assigned study biliary access technique
Time frame: Intra-procedure, during ERCP
Need for rescue biliary drainage procedures in patients with failed biliary access by the assigned study technique, including crossover to the other study biliary access technique, need for PTBD by interventional radiology
Time frame: Intra-procedure (during ERCP) and 3 days post procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Bile Duct Diseases
Active, not recruitingPhase 3
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Primary Biliary Cirrhosis
RecruitingPhase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
RecruitingPhase 3
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Primary Biliary Cholangitis (PBC)
RecruitingPhase 1/2
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Biliary Cancer, Bile Duct Cancer
RecruitingPhase 3
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Primary Biliary Cirrhosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Raymond Tang, MD principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EUS-guided rendezvous and Early precut papillotomy group in people with Bile Duct Diseases, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Felix Sia (26370428, felixsia@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The first session technical success for biliary access by EUS-guided rendezvous technique and early precut papillotomy in patients with difficult biliary access during ERCP (time frame: Intra-procedure, during ERCP). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.